➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Dow
Medtronic
AstraZeneca
Baxter
Harvard Business School

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Litigation Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-06-26
Court District Court, D. New Jersey Date Terminated
Cause 15:1126 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Douglas Arpert
Parties AUROBINDO PHARMA LIMITED
Patents 10,092,541; 6,962,940; 7,208,516; 7,427,638; 7,659,302; 7,893,101; 8,455,536; 8,802,717; 9,018,243; 9,724,330; 9,872,854
Attorneys KARIN KRAFT SAGE
Firms Windels, Marx, Lane & Mittendorf, LLP
Link to Docket External link to docket
Small Molecule Drugs cited in AMGEN INC v. SANDOZ INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in AMGEN INC v. SANDOZ INC.

Details for AMGEN INC v. SANDOZ INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-06-26 1 Complaint United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (“… U.S. Patent Nov. 8, 2005 Sheet 1 of 2 US 6,962,940 B2 …PageID: 71 U.S. Patent Nov. 8, 2005 Sheet 2 of 2 US 6,962,940 B2 … US 6,962,940 B2 Muller et al. (45) Date… US 6,962,940 B2 External link to document
2018-11-06 42 Amended Complaint 330 Patent”), 9,872,854 (“the ’854 Patent”), and 10,092,541 (“the ’541 Patent”) (collectively, “the Patents-in… United States Patent Nos. 6,962,940 (“the ’940 Patent”), 7,208,516 (“the ’516 Patent”), 7,427,638 (… (“the ’638 Patent”), 7,659,302 (“the ’302 Patent”), 7,893,101 (“the ’101 Patent”), 8,455,536 (“the …the ’536 Patent”), 8,802,717 (“the ’717 Patent”), 9,018,243 (“the ’243 Patent”), 9,724,330 (“the ’330 … This is a civil action for patent infringement arising under the patent laws of the United States, External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
McKesson
Colorcon
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.